The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

Tue, 14th Jul 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

CREDIT SUISSE RAISES HALMA PRICE TARGET TO 2530 (2030) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES JOHNSON MATTHEY TARGET TO 3500 (3400) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES CRODA INTERNATIONAL TARGET TO 5100 (4500) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES FLUTTER PRICE TARGET TO 10500 (10000) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES SMITHS PRICE TARGET TO 1530 (1300) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS STANDARD CHARTERED PRICE TARGET TO 690 (730) PENCE - 'BUY'

----------

GOLDMAN CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 195 (215) PENCE - 'BUY'

----------

GOLDMAN CUTS LLOYDS BANKING PRICE TARGET TO 29 (32) PENCE - 'SELL'

----------

GOLDMAN CUTS BARCLAYS PRICE TARGET TO 135 (150) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS HSBC TO 'BUY' ('CONVICTION BUY LIST') - PRICE TARGET 565 (695) PENCE

----------

DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 135 (208) PENCE - 'BUY'

----------

DEUTSCHE BANK RESUMES STANDARD CHARTERED WITH 'HOLD' - TARGET 415 PENCE

----------

DEUTSCHE BANK RESUMES RBS WITH 'SELL' - TARGET 100 PENCE

----------

DEUTSCHE BANK REINITIATES LLOYDS BANKING WITH 'HOLD' - PRICE TARGET 34 PENCE

----------

DEUTSCHE BANK REINITIATES HSBC WITH 'SELL' - PRICE TARGET 335 PENCE

----------

JPMORGAN RAISES LEGAL & GENERAL TARGET TO 202 (200) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

DEUTSCHE BANK RAISES G4S TO 'BUY' ('HOLD') - TARGET 160 (140) PENCE

----------

DEUTSCHE BANK RESUMES VIRGIN MONEY WITH 'BUY' - TARGET 105 PENCE

----------

JPMORGAN CUTS JOHN WOOD PRICE TARGET TO 400 (590) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES AVON RUBBER PRICE TARGET TO 3510 (2435) PENCE - 'HOLD'

----------

BERENBERG CUTS PRIMARY HEALTH PROPERTIES TO 'HOLD' ('BUY') - TARGET 155 (150) PENCE

----------

BERENBERG CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 200 (190) PENCE

----------

BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 200 (210) PENCE - 'OVERWEIGHT'

----------

RBC RAISES BODYCOTE PRICE TARGET TO 710 (650) PENCE - 'OUTPERFORM'

----------

RBC RAISES MORGAN ADVANCED TO SECTOR PERFORM ('UNDERPERFORM') - TARGET 275 (250) PENCE

----------

RBC CUTS ROTORK TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 275 (265) PENCE

----------

RBC RAISES IMI TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1140 (1000) PENCE

----------

GOLDMAN CUTS VIRGIN MONEY PRICE TARGET TO 95 (100) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING TARGET TO 180 (170) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SPIRENT PRICE TARGET TO 325 (290) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RESUMES MITIE GROUP WITH 'HOLD' - TARGET 43 PENCE

----------

BERENBERG RAISES CONNECT GROUP TO 'BUY' ('HOLD') - TARGET 27 (15) PENCE

----------

DEUTSCHE BANK CUTS FORTERRA PRICE TARGET TO 234 (340) PENCE - 'BUY'

----------

BERNSTEIN CUTS BOOHOO PRICE TARGET TO 350 (480) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS KENMARE RESOURCES PRICE TARGET TO 370 (380) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 1300 (1500) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS HUNTING PRICE TARGET TO 210 (460) PENCE - 'NEUTRAL'

----------

RBC RAISES RESTAURANT GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 80 (70) PENCE

----------

GOLDMAN CUTS BANK OF IRELAND PRICE TARGET TO 1.75 (2) EUR - 'NEUTRAL'

----------

GOLDMAN CUTS AIB GROUP PRICE TARGET TO 1.80 (2.20) EUR - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 Apr 2021 08:37

Clinigen to launch 'Erwinase' in the UK earlier than planned

(Sharecast News) - Pharmaceutical products and services company Clinigen Group announced on Tuesday that it will be providing access to 'Erwinase', or L-asparaginase Erwinia chrysanthemi, in the UK from 6 April.

Read more
24 Mar 2021 14:38

EXECUTIVE CHANGES: Experian appoints Sage Group CFO as non-executive

EXECUTIVE CHANGES: Experian appoints Sage Group CFO as non-executive

Read more
11 Mar 2021 16:10

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
5 Mar 2021 13:07

Friday broker round-up

(Sharecast News) - Aggreko: Peel Hunt upgrades to hold with a target price of 880p.

Read more
23 Feb 2021 13:39

Tuesday broker round-up

(Sharecast News) - Clinigen: Liberum reiterates buy with a target price of 1,050p.

Read more
23 Feb 2021 09:35

Clinigen Maintains Interim Payout And Expects Revenue Growth In Year

Clinigen Maintains Interim Payout And Expects Revenue Growth In Year

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Feb 2021 10:07

Clinigen Simplifies Structure, Moves To Two Reporting Units From Three

Clinigen Simplifies Structure, Moves To Two Reporting Units From Three

Read more
1 Feb 2021 13:44

Monday broker round-up

(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.

Read more
14 Jan 2021 12:09

IN BRIEF: Clinigen Expects Drop In Interim Earnings Despite Revenue

IN BRIEF: Clinigen Expects Drop In Interim Earnings Despite Revenue

Read more
4 Jan 2021 09:56

Clinigen Appoints Former World Courier President As Operating Chief

Clinigen Appoints Former World Courier President As Operating Chief

Read more
26 Nov 2020 10:45

Clinigen Trading In Line With Expectations, Reiterates Guidance

Clinigen Trading In Line With Expectations, Reiterates Guidance

Read more
26 Nov 2020 09:18

Clinigen trades in line despite ongoing Covid-19 impact

(Sharecast News) - Pharmaceutical and services company Clinigen said on Thursday that trading had been in-line with market expectations despite the ongoing impact of the Covid-19 pandemic.

Read more
25 Nov 2020 16:03

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
25 Nov 2020 09:28

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.